In a subsequent study, we demonstrated that germ-line Arg2 deletion and adoptive transfer of Arg2−/− CD8+ T cells significantly reduce tumor growth in preclinical cancer models by enhancing CD8+ T cell activation, and endowing these cells with more robust cytotoxic function, memory T cell formation, and persistence [215]. Here, CD8A is linked to cancer.